145 related articles for article (PubMed ID: 8957673)
21. Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.
Smith AD; Geisler SC; Chen AA; Resnick DA; Roy BM; Lewi PJ; Arnold E; Arnold GF
J Virol; 1998 Jan; 72(1):651-9. PubMed ID: 9420270
[TBL] [Abstract][Full Text] [Related]
22. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE
Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701
[TBL] [Abstract][Full Text] [Related]
23. Engineering of noninfectious HIV-1-like particles containing mutant gp41 glycoproteins as vaccine candidates that allow vaccinees to be distinguished from HIV-1 infectees.
Rovinski B; Dekaban GA; Cao SX; Yao FL; Persson R; Matthews TJ; Klein MH
Virology; 1999 May; 257(2):438-48. PubMed ID: 10329554
[TBL] [Abstract][Full Text] [Related]
24. Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
Yi G; Lapelosa M; Bradley R; Mariano TM; Dietz DE; Hughes S; Wrin T; Petropoulos C; Gallicchio E; Levy RM; Arnold E; Arnold GF
PLoS One; 2013; 8(9):e72205. PubMed ID: 24039745
[TBL] [Abstract][Full Text] [Related]
25. Expression & immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus.
Yasawardene SG; Lomonossoff GP; Ramasamy R
Indian J Med Res; 2003 Sep; 118():115-24. PubMed ID: 14700344
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5.
Kusov YY; Zamjatina NA; Poleschuk VF; Michailov MI; Morace G; Eberle J; Gauss-Müller V
Antiviral Res; 2007 Feb; 73(2):101-11. PubMed ID: 17014915
[TBL] [Abstract][Full Text] [Related]
27. Capsid proteins of cowpea mosaic virus transiently expressed in protoplasts form virus-like particles.
Wellink J; Verver J; Van Lent J; Van Kammen A
Virology; 1996 Oct; 224(1):352-5. PubMed ID: 8862434
[TBL] [Abstract][Full Text] [Related]
28. [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].
Meshcheriakova IuA; El'darov MA; Migunov AI; Stepanova LA; Repko IA; Kiselev OI; Lomonosov DP; Skriabin KG
Mol Biol (Mosk); 2009; 43(4):741-50. PubMed ID: 19807038
[TBL] [Abstract][Full Text] [Related]
29. ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41.
Dong XN; Xiao Y; Chen YH
Immunol Lett; 2001 Jan; 75(2):149-52. PubMed ID: 11137140
[TBL] [Abstract][Full Text] [Related]
30. A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
Meador LR; Kessans SA; Kilbourne J; Kibler KV; Pantaleo G; Roderiguez ME; Blattman JN; Jacobs BL; Mor TS
Virology; 2017 Jul; 507():242-256. PubMed ID: 28458036
[TBL] [Abstract][Full Text] [Related]
31. The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens.
Davis D; Chaudhri B; Stephens DM; Carne CA; Willers C; Lachmann PJ
J Gen Virol; 1990 Sep; 71 ( Pt 9)():1975-83. PubMed ID: 2170568
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state.
Kim M; Qiao Z; Yu J; Montefiori D; Reinherz EL
Vaccine; 2007 Jun; 25(27):5102-14. PubMed ID: 17055621
[TBL] [Abstract][Full Text] [Related]
33. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
[TBL] [Abstract][Full Text] [Related]
34. Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein.
Benen TD; Tonks P; Kliche A; Kapzan R; Heeney JL; Wagner R
J Biomed Sci; 2014 Aug; 21(1):79. PubMed ID: 25160824
[TBL] [Abstract][Full Text] [Related]
35. Cowpea mosaic virus as a vaccine carrier of heterologous antigens.
Brennan FR; Jones TD; Hamilton WD
Mol Biotechnol; 2001 Jan; 17(1):15-26. PubMed ID: 11280928
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution.
Lin T; Porta C; Lomonossoff G; Johnson JE
Fold Des; 1996; 1(3):179-87. PubMed ID: 9079380
[TBL] [Abstract][Full Text] [Related]
39. Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope.
Li J; Chen X; Jiang S; Chen YH
Biochem Biophys Res Commun; 2008 Nov; 376(1):60-4. PubMed ID: 18762167
[TBL] [Abstract][Full Text] [Related]
40. Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.
Panicali DL; Mazzara G; Sullivan JL; Hesselton R; Shen L; Letvin N; Daniel M; Desrosiers R; Stott EJ
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1449. PubMed ID: 1466979
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]